Month: February 2025

Tuesday, 25 February 2025 | SAINT HELIER, Jersey – CoinShares International Limited (“CoinShares” or the “Company“) (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), a global investment firm specializing in digital assets, today announced that it has agreed to enter a block transaction with a shareholder to acquire 200,000 ordinary shares in the capital of the Company. Subject to completion of the block transaction, the Company will repurchase from the selling shareholder a total 200,000 ordinary shares at a price per share equal to SEK 75 resulting in total consideration of SEK 15,000,000. The Company expects the block transaction to settle via cash and to complete before 28 February 2025. CoinShares’ decision to repurchase its shares is consistent with the Board’s stated intent regarding the buyback program...

FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for the 505(b)(2) regulatory registration pathway for approval Adial moves forward with manufacturing of clinical supplies for upcoming Phase 3 clinical program in 2025 GLEN ALLEN, Va., Feb. 25, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced a positive response from the U.S. Food and Drug Administration (FDA) regarding its proposed in vitro bridging strategy for AD04. The FDA’s feedback follows Adial’s submission on November 19, 2024, in which the Company sought the Agency’s guidance on the alignment...

Magillem Registers is a comprehensive register design and management technology that accurately automates the hardware/software interface (HSI) to quickly develop chips and chiplets ranging from IoT devices to complex AI datacenter multi-die SoCs.Highlights:Solution Integration: Integration of acquired silicon-proven Magillem 5 and Semifore CSRCompiler products into a next-generation ‘single source of truth’ software product for register management and Hardware/Software Interface automation. Any Design: Up to 3x expanded performance and 5x scalability address today’s SoCs and FPGA designs, ranging from simple IoT devices to state-of-the-art complex AI SoCs. Broad Standards Support: Augments existing support of IEEE 1685-2009 (IP-XACT) standard with support of the 2014 and 2022 versions, and that of Accellera SystemRDL...

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI”) (OTCQB: ASPU), an education technology holding company, today announced that Aspen University (AU) has received notification of its renewal of accreditation from the Distance Education Accrediting Commission (DEAC), which is listed by the U.S. Department of Education as a recognized accrediting agency and recognized by the Council for Higher Education Accreditation (CHEA). The commission granted accreditation renewal to AU for five years through January 2029, the maximum accreditation period permitted by DEAC. Accreditation by DEAC is a reliable indicator of the value and quality of the distance education that an institution offers. In receiving this renewal of accreditation, AU has demonstrated its commitment to educational standards and ethical business...

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences: TD Cowen 45th Annual Health Care ConferenceMarch 3, 20253:10 p.m. ET – fireside chat Leerink Partners 2025 Global Healthcare ConferenceMarch 10, 20253:00 p.m. ET – fireside chat A simultaneous webcast of the events will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days. About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation...

Trailblazing licensed wholesaler embraces Kornit Apollo to boost production efficiency, overcome labor challenges, and deliver top-quality apparel faster than ever before Transition from traditional screen printing to cutting-edge digital production positions American Classics to better meet growing e-commerce and retail demandsROSH-HA’AYIN, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) — Kornit Digital LTD. (NASDAQ: KRNT) (“Kornit” or the “Company”), a global pioneer in sustainable, on-demand digital fashion and textile production technologies, today announced that American Classics Apparel, Inc., a top wholesaler of licensed music, movie, and gaming apparel, is adopting the Kornit Apollo platform. This next-generation direct-to-garment powerhouse accelerates the company’s shift from traditional screen printing to high-speed...

BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor meetings throughout the event. The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com. About AnikaAnika...